Encompass Health Corporation (EHC) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY25 Guidance

Encompass Health Corporation (NYSE: EHC) reported Q4 EPS of $1.17, $0.14 better than the analyst estimate of $1.03. Revenue for the quarter came in at $1.41 billion versus the consensus estimate of $1.38 billion.

GUIDANCE:

Encompass Health Corporation sees FY2025 EPS of $4.67-$4.96, versus the consensus of $4.77. Encompass Health Corporation sees FY2025 revenue of $5.8-5.9 billion, versus the consensus of $5.83 billion.

For earnings history and earnings-related data on Encompass Health Corporation (EHC) click here.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• Jefferies Starts Louisiana-Pacific Corp (LPX) at Buy
• Barclays Starts DKSH Holding AG (DKSH:SW) at Overweight